Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The MS-LINK™ Outcomes Study: A Comprehensive Prospective Longitudinal Assessment of Patient and Clinical Reported Outcomes in Multiple Sclerosis Patients Across North America

NCT04735406 is registered in ClinicalTrials.gov with EMD Serono Research & Development Institute, Inc. as lead sponsor.

NCT NCT04735406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04735406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The MS-LINK™ Outcomes Study: A Comprehensive Prospective Longitudinal Assessment of Patient and Clinical Reported Outcomes in Multiple Sclerosis Patients Across North America
Lead sponsor
EMD Serono Research & Development Institute, Inc.
Phase
Observational
Overall status
Completed
Start date
March 24, 2021
Completion date
May 31, 2024
Enrollment
2,182 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis